Items where authors include "Crouch, S"

Article

Abani, O, Abbas, A, Abbas, F et al. (6300 more authors) (2022) Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 399 (10325). pp. 665-676. ISSN 0140-6736

Abani, O, Abbas, A, Abbas, F et al. (4809 more authors) (2021) Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial. The Lancet, 397 (10289). pp. 2049-2059. ISSN 0140-6736

Abani, O orcid.org/0000-0003-2209-9956, Abbas, A, Abbas, F et al. (6346 more authors) (2021) Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 397 (10285). pp. 1637-1645. ISSN 0140-6736

Cucco, F, Barrans, S, Sha, C et al. (21 more authors) (2020) Distinct genetic changes reveal evolutionary history and heterogeneous molecular grade of DLBCL with MYC/BCL2 double-hit. Leukemia, 34. pp. 1329-1341. ISSN 0887-6924

Painter, D, Barrans, S, Lacy, S et al. (8 more authors) (2019) Cell‐of‐origin in diffuse large B‐cell lymphoma: findings from the UK's population‐based Haematological Malignancy Research Network. British Journal of Haematology, 185 (4). pp. 781-784. ISSN 0007-1048

Smith, A, Howell, D, Crouch, S et al. (10 more authors) (2018) Cohort Profile: The Haematological Malignancy Research Network (HMRN): a UK population-based patient cohort. International Journal of Epidemiology, 47 (3). 700-700g. ISSN 0300-5771

Kane, E, Howell, D, Smith, A et al. (4 more authors) (2017) Emergency admission and survival from aggressive non-Hodgkin lymphoma: A report from the UK's population-based Haematological Malignancy Research Network. European Journal of Cancer, 78. pp. 53-60. ISSN 0959-8049